A cancer-specific pipeline uncovers MCM3 as a driver of glioblastoma progression via suppression of the Wnt pathway

Key Points

• MCM3 drives glioblastoma progression by inhibiting the Wnt pathway, which affects tumor growth.
• Significant findings noted with MCM3 levels correlating with tumor aggressiveness and Wnt pathway suppression.
• Analysis performed using a cancer-specific pipeline to assess molecular interactions in glioblastoma.
• Findings suggest that targeting MCM3 may provide a new strategy for glioblastoma therapies.